Litcius/Paper detail

Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy

Nathan Watson, Hanny Al‐Samkari

2021Journal of Thrombosis and Haemostasis50 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMalignancyInternal medicineAngiogenesisGastroenterologyOncologyCardiologyAngiogenesis and VEGF in CancerAntiplatelet Therapy and Cardiovascular DiseasesChemotherapy-induced cardiotoxicity and mitigation
Thrombotic and bleeding risk of angiogenesis inhibitors in patients with and without malignancy | Litcius